TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
TFA Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $882.53K. For fiscal 2025 it was $1.25M, down 0.6% from the year before. The highest annual figure on record is $1.25M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25M | -0.6% |
| FY2024 | Dec 31, 2024 | $1.25M | +42.0% |
| FY2023 | Dec 31, 2023 | $882.53K | +1555.7% |
| FY2022 | Dec 31, 2022 | $53.30K | -93.9% |
| FY2021 | Dec 31, 2021 | $879.32K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $315.50K | – |
See a number that looks wrong?